Snke H. Bartling1, Johannes Budjan1,
Hagit Aviv2, Henrik J. Michaely1, Wolfhard Semmler3,
Stefan O. Schnberg1, Steffen Diehl1, Shlomo Margel2,
Maliha Sadick1
1Clinical Radiology and Nuclear
Medicine, University Medical Center, Mannheim, Baden-Wrttemberg, Germany; 2Dept.
of Chemistry, Bar-Ilan University, Ramat-Gan, Israel; 3Dept. of
Medical Physics in Radiology, German Cancer Research Center, Heidelberg,
Germany
MRI
guidance of interventions is a goal. Current embolization particles cannot be
detected by an imaging modality (clinical) or only by CT/X-ray (research).
Here, we developed and tested the first multimodal embolization particles
being visible within MRI and CT/x-ray. An animal model was used. Post
embolization imaging confirmed dual-modality contrast as embolized areas
could be detected by CT and MRI. Histology confirmed results. The particles
consist of two clinically approved substances: polymerized Iodine and USPIO.
Once introduced into clinical routine, improvements of embolization therapy
can be expected, because both CT and MRI could be used for treatment control.